in the news
Global Legal Chronicle: RemeGen’s A-share IPO and Listing on SSE STAR MarketApril 08, 2022
O’Melveny represented RemeGen Co., Ltd. as its Hong Kong legal advisor in its A-share listing on the Sci-Tech Innovation Board of the Shanghai Stock Exchange. The A-share listing was completed on March 31, 2022. RemeGen raised approximately RMB2.6 billion from the transaction. The O’Melveny team for the A-share listing of RemeGen was led by Hong Kong corporate partner Edwin Kwok, with support from Hong Kong corporate counsel Wendy Kan and associate Michelle Ye.
Read the full article here.